Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Technology Assessment in Health Care|October 3, 2008
How is magnetic resonance imaging used in Iran?Mohammad Palesh, Sten Fredrikson, Hamidreza Jamshidi, et al.
International Journal of Technology Assessment in Health Care|May 12, 2007
Diffusion of magnetic resonance imaging in IranMohammad Palesh, Sten Fredrikson, Hamidreza Jamshidi, et al.
In Vitro Cellular & Developmental Biology. Animal|September 14, 2016
Evaluating cytotoxic effect of nanoliposomes encapsulated with umbelliprenin on 4T1 cell lineMohsen Rashidi, Alireza Ahmadzadeh, Seyed Ali Ziai, et al.
Scientific Reports|January 3, 2024
Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal modelAsghar Abdoli, Hamidreza Jamshidi, Mohammad Taqavian, et al.
Health Research Policy and Systems|April 8, 2010
"We noticed that suddenly the country has become full of MRI". Policy makers' views on diffusion and use of health technologies in IranMohammad Palesh, Carol Tishelman, Sten Fredrikson, et al.
Arthroplasty Today|August 5, 2025
One-Stage Primary Total Knee Arthroplasty as the Treatment of Acute Septic Arthritis of the Native Osteoarthritic Knee: Report of 3 Cases and Review of LiteratureMohammad Mahdi Sarzaeem, Davood Feizi, Hamidreza Jamshidi Kouhsari, et al.
Pharmacoepidemiology and Drug Safety|May 30, 2008
Diffusion of interferon beta in Iran and its utilization in TehranMohammad Palesh, Pia Maria Jonsson, Hamidreza Jamshidi, et al.
Archives of Iranian Medicine|October 2, 2007
Determinants of seeking needed outpatient care in Iran: results from a national health services utilization surveyAhmad-Reza Hosseinpoor, Mohsen Naghavi, Seyed Moayed Alavian, et al.
Head & Neck|June 18, 2026
Current State and Future of Systemic Treatment for Elderly Patients With Head and Neck Cancer Undergoing RadiotherapyPardis Zamani, Erfan Barootchi, Romina Abyaneh, et al.
Iranian Red Crescent Medical Journal|October 6, 2016
Umbelliprenin is Potentially Toxic Against the HT29, CT26, MCF-7, 4T1, A172, and GL26 Cell Lines, Potentially Harmful Against Bone Marrow-Derived Stem Cells, and Non-Toxic Against Peripheral Blood Mononuclear CellsMohsen Rashidi, Seyed Ali Ziai, Taraneh Moini Zanjani, et al.
Pageof 5